Cytal™ Wound Matrix (1-Layer, 2-Layer, 3-Layer, 6-Layer)
Cytal™ Wound Matrix is a sterile, porcine-derived, naturally-occurring lyophilized extracellular matrix in sheet form that maintains and supports a healing environment for wound management.
• Maintains and supports a healing environment through constructive remodeling
• Comprised of naturally-occurring urinary bladder matrix
• Contains basement membrane and numerous collagens
• Maintains an intact epithelial basement membrane
• Non-crosslinked wound management scaffold
• Appropriate for acute and chronic wounds
• Complements standard of care
• Fenestrated sheets
Cytal™ Wound Matrix is intended for the management of wounds including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns, and skin tears), and draining wounds. This device is intended for one-time use.
Contraindicated for use on patients with known sensitivity or allergy to porcine materials and third-degree burns.
Cytal™ Wound Matrix is intended for one-time use. Do not re-use or sterilize. Do not use if package seal has been broken. Complications and reactions are possible with any soft tissue repair, including but not limited to: infection, increased chronic inflammation, allergic reaction, unexplained fever or chills, excessive redness, pain or swelling.
Store in a clean, dry environment between 15°C-35°C (59°F-95°F) in unopened and undamaged package.
|Assigned HCPCS code||●|
|Shelf life greater than 2 years|
|Shelf life limited|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for second-degree burns|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
Clean wound bed by removing necrotic tissue and scar tissue to obtain fresh tissue edges. Irrigate excessive exudates and control bleeding. Remove Cytal™ Wound Matrix from container using standard aseptic methods. Cut device slightly bigger than area of wound to be covered. Rehydrate Cytal™ Wound Matrix in room temperature sterile saline or sterile lactated Ringer's solution in a sterile dish for five minutes prior to use.
Large wound: More than one device may be needed to cover wound area. Overlap Cytal™ Wound Matrix edges slightly to ensure complete coverage.
Wet wound: Cover device with non-adherent dressing such as petrolatum gauze, followed by application of an absorptive dressing such as a calcium alginate. Secure dressings to wound site.
Dry wound: The non-adherent dressing should be followed by application of a hydrogel dressing to keep wound moist. Secure dressings to wound site. Keep device and wound bed moist.
Inspect wound for adverse reactions every seven days; remove exudates and apply new Cytal™ Wound Matrix to any non-covered wound areas. Do not remove any remaining device that is intact on wound surface. As Cytal™ Wound Matrix is resorbed, it may form a caramel-colored gel. Rinse wound surface gently leaving the caramel-colored gel intact and re-apply another device. Repeat wound care follow-up process weekly until wound has epithelialized. Monitor tissue surrounding edges of wound.
ACell, Inc. offers Cytal™ and MicroMatrix® products that maintain and support a healing environment through constructive remodeling. Indicated for acute and chronic wounds.